Drug abuse affects our families, workplaces and communities. Toxicity of certain prescription medications can also be a serious health concern for patients and health care professionals.
For in vitro diagnostic use only.
Abbott offers many assays to determine the presence of commonly abused drugs and toxic levels of prescription medications across harmonized systems to deliver the performance you need and expect in your laboratory.
When your laboratory needs assays to show evidence of drug abuse or toxic levels of medications in patients, our wide variety of assays for drugs of abuse and toxicology on a routine clinical chemistry analyzer allows for consolidation on a single, fully automated instrument. This capability offers reliable performance with increased operational efficiency.
| Drugs of Abuse/Toxicology |
|---|
| Acetaminophen |
| Amphetamine/ Methamphetamine |
| Barbiturates |
| Benzodiazepines (Serum) |
| Benzodiazepines |
| Cannabinoids |
| Cocaine |
| Ecstasy |
| Ethanol |
| Methadone |
| Opiates |
| PCP (Phencyclidine) |
| Propoxyphene |
| Salicylate |
| Tricyclic Antidepressants |
Diagnostics at Abbott offers a complete portfolio of integrated solutions including Core Laboratory, Molecular, Point of Care, Rapid Diagnostics and Transfusion Medicine.
Find the latest information in laboratory science, therapeutic areas and Abbott innovation.
Receive exclusive benefits and resources when you register to access to the Customer Portal.
Abbott's Representatives are ready to offer support, gather feedback, and answer any questions.
Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott. The website that you have requested also may not be optimised for your screen size.
Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.
